78 related articles for article (PubMed ID: 2411437)
21. [Results and prognostic factors in the treatment of chronic active hepatitis with prednisone and azathioprine].
Jorge AD; Sánchez D
Acta Gastroenterol Latinoam; 1985; 15(4):233-41. PubMed ID: 3842554
[TBL] [Abstract][Full Text] [Related]
22. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
[TBL] [Abstract][Full Text] [Related]
23. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
Maier KP; Lepiorz H; Berthold H; Gerok W
Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
[TBL] [Abstract][Full Text] [Related]
24. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
[TBL] [Abstract][Full Text] [Related]
26. Isoprinosine in the treatment of chronic active hepatitis type B.
Cianciara J; Laskus T; Gabinska E; Loch T
Scand J Infect Dis; 1990; 22(6):645-8. PubMed ID: 1704640
[TBL] [Abstract][Full Text] [Related]
27. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of chronic active hepatitis caused by hepatitis B virus infection].
Degos F; Marcellin P; Benhamou JP
Gastroenterol Clin Biol; 1988 Nov; 12(11):845-54. PubMed ID: 2464521
[No Abstract] [Full Text] [Related]
30. Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood.
Tolentino P; Jannuzzi C; Giacchino R
Infection; 1983; 11(5):255-9. PubMed ID: 6642677
[TBL] [Abstract][Full Text] [Related]
31. [Therapy of chronic hepatitis (author's transl)].
Siede W
Dtsch Z Verdau Stoffwechselkr; 1979; 39(2):57-69. PubMed ID: 378653
[TBL] [Abstract][Full Text] [Related]
32. Clinical pathological study of treatment of chronic hepatitis with hyperbaric oxygenation.
Liu W; Zhao W; Lu X; Zheng X; Luo C
Chin Med J (Engl); 2002 Aug; 115(8):1153-7. PubMed ID: 12215281
[TBL] [Abstract][Full Text] [Related]
33. [Preliminary evaluation of the results of treatment of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa)].
Juszczyk J
Pol Tyg Lek; 1984 Aug; 39(33):1085-9. PubMed ID: 6504737
[No Abstract] [Full Text] [Related]
34. Chronic active hepatitis.
Kolts BE; Spindel E
Am Fam Physician; 1984 Jun; 29(6):228-43. PubMed ID: 6203393
[No Abstract] [Full Text] [Related]
35. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
36. Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it?
Ascione A; Amitrano L; Riccio E; De Lella A; Canestrini C; de Bellis G; D'Alessandro R; Fiore R; Padulano P
Hepatogastroenterology; 1984 Jun; 31(3):123-4. PubMed ID: 6469200
[TBL] [Abstract][Full Text] [Related]
37. [Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)].
Pár A; Beró T; Brasch G; Gógl A; Kamarás G; Méhesfalvi E; Ozsvár Z; Paál M; Szipöcs I; Telegdy L
Orv Hetil; 1993 May; 134(19):1015-9. PubMed ID: 7684118
[TBL] [Abstract][Full Text] [Related]
38. [Chronic hepatitis caused by B virus (HBV)].
Di Nola F; Soranzo ML; Angela GC; Salassa B; Bramato C; Fiorio C; Marino M; Bendiscioli L
Minerva Med; 1980 Apr; 71(14):1009-26. PubMed ID: 7375013
[TBL] [Abstract][Full Text] [Related]
39. Follow-up ten years after corticosteroid therapy for chronic active hepatitis type B.
Tsuji T; Naito K; Tokuyama K; Okada T; Takata S; Araki K; Shinohara T; Inoue J; Onoue K; Tsuchiya M; Nozaki H; Nagashima H; Hamaya K
Hepatogastroenterology; 1980 Apr; 27(2):85-90. PubMed ID: 7011930
[TBL] [Abstract][Full Text] [Related]
40. Treatment of chronic active hepatitis--present state. The pros and cons of immunosuppressive therapy.
Thaler H
Hepatogastroenterology; 1984 Feb; 31(1):6-11. PubMed ID: 6698488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
